Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Judge

Showing results (201-210 of 260) with videos related to

Pageof 26
Sort By:
Journal of the American College of Cardiology|June 4, 2011
Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noiseJamie D Kapplinger, Andrew P Landstrom, Benjamin A Salisbury, et al.
Heart Rhythm|February 21, 2017
Cardiac phenotype and long-term prognosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients with late presentationAditya Bhonsale, Anneline S J M Te Riele, Abhishek C Sawant, et al.
The New England Journal of Medicine|August 28, 2018
Tafamidis Treatment for Patients with Transthyretin Amyloid CardiomyopathyMathew S Maurer, Jeffrey H Schwartz, Balarama Gundapaneni, et al.
Journal of Cardiovascular Electrophysiology|July 30, 2013
Mutation-positive arrhythmogenic right ventricular dysplasia/cardiomyopathy: the triangle of dysplasia displacedAnneline S J M Te Riele, Cynthia A James, Binu Philips, et al.
JACC. Heart Failure|July 13, 2020
Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac AmyloidosisVirginia S Hahn, Lisa R Yanek, Joban Vaishnav, et al.
Journal of the American College of Cardiology|October 27, 2025
Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM: Exploratory Analysis From ATTRibute-CMAhmad Masri, Daniel P Judge, Frederick L Ruberg, et al.
The New England Journal of Medicine|January 10, 2024
Efficacy and Safety of Acoramidis in Transthyretin Amyloid CardiomyopathyJulian D Gillmore, Daniel P Judge, Francesco Cappelli, et al.
European Journal of Heart Failure|June 19, 2019
Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel reportPerry M Elliott, Aris Anastasakis, Angeliki Asimaki, et al.
Circulation. Genomic and Precision Medicine|August 7, 2019
Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Desmosomal Variants Are Rarely De NovoFreyja H M van Lint, Brittney Murray, Crystal Tichnell, et al.
The Journal of Clinical Investigation|December 21, 2013
Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesisElena M Gallo, David C Loch, Jennifer P Habashi, et al.
Pageof 26

Showing results (201-210 of 260) with videos related to

Sort By:
Pageof 26
Journal of the American College of Cardiology|June 4, 2011
Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noiseJamie D Kapplinger, Andrew P Landstrom, Benjamin A Salisbury, et al.
Heart Rhythm|February 21, 2017
Cardiac phenotype and long-term prognosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients with late presentationAditya Bhonsale, Anneline S J M Te Riele, Abhishek C Sawant, et al.
The New England Journal of Medicine|August 28, 2018
Tafamidis Treatment for Patients with Transthyretin Amyloid CardiomyopathyMathew S Maurer, Jeffrey H Schwartz, Balarama Gundapaneni, et al.
Journal of Cardiovascular Electrophysiology|July 30, 2013
Mutation-positive arrhythmogenic right ventricular dysplasia/cardiomyopathy: the triangle of dysplasia displacedAnneline S J M Te Riele, Cynthia A James, Binu Philips, et al.
JACC. Heart Failure|July 13, 2020
Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac AmyloidosisVirginia S Hahn, Lisa R Yanek, Joban Vaishnav, et al.
Journal of the American College of Cardiology|October 27, 2025
Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM: Exploratory Analysis From ATTRibute-CMAhmad Masri, Daniel P Judge, Frederick L Ruberg, et al.
The New England Journal of Medicine|January 10, 2024
Efficacy and Safety of Acoramidis in Transthyretin Amyloid CardiomyopathyJulian D Gillmore, Daniel P Judge, Francesco Cappelli, et al.
European Journal of Heart Failure|June 19, 2019
Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel reportPerry M Elliott, Aris Anastasakis, Angeliki Asimaki, et al.
Circulation. Genomic and Precision Medicine|August 7, 2019
Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Desmosomal Variants Are Rarely De NovoFreyja H M van Lint, Brittney Murray, Crystal Tichnell, et al.
The Journal of Clinical Investigation|December 21, 2013
Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesisElena M Gallo, David C Loch, Jennifer P Habashi, et al.
Pageof 26